SUMMARY Human herpesvirus 6 (HHV-6) is a betaherpesvirus that is closely related to
human cytomegalovirus. It was discovered in 1986, and HHV-6 literature has expanded …

Infectious diseases after solid organ transplantation (SOT) are a significant cause of
morbidity and reduced allograft and patient survival; however, the influence of infection on …

Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Human herpesvirus 6 (HHV-6) reactivation has been associated with acute graft-versus-host-
disease (aGVHD), cytomegalovirus reactivation, and mortality after allogeneic hematopoietic …

Human herpesvirus 6 infects virtually all children within the first few years of life and like
other herpesviruses, establishes latency after primary infection. In immunocompromised …

Abstract Background Human herpesviruses (HHVs) remain latent after primary infection and
can be reactivated in response to immunosuppression and chemotherapy. Little is known …

Human herpesvirus 6 (HHV-6) exists as distinct variants HHV-6A and HHV-6B. The
complete genomes of HHV-6A and HHV-6B have been sequenced. HHV-6B contains 97 …

Summary Human herpesvirus‐6 (HHV‐6), which comprises of HHV‐6A and HHV‐6B, is a
common infection after solid organ transplantation. The rate of HHV‐6 reactivation is high …

Serial monitoring of peripheral blood lymphocyte subpopulations (PBLS s) counts might be
useful in predicting post‐transplant opportunistic infection (OI) after kidney transplantation …